SMX FY 2025 net loss widens to USD 174.59 million as R&D expenses more than tripled to USD 11.23 million

Reuters
昨天
SMX FY 2025 net loss widens to USD 174.59 million as R&D expenses more than tripled to USD 11.23 million
  • SMX published an annual report on Form 20-F for the fiscal year ended Dec. 31, 2025.
  • The company reported no revenue and a net loss of USD 174.59 million.
  • Operating loss was USD 146.29 million, while general and administrative expenses were USD 120.1 million.
  • Research and development expenses were USD 11.23 million and selling and marketing expenses were USD 4.11 million.
  • Cash and cash equivalents were USD 12.2 million at year-end, and management said the financial statements include an explanatory paragraph about substantial doubt regarding the company’s ability to continue as a going concern.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SMX (Security Matters) plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-011985), on March 20, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10